|
Τίτλος – Title
|
New Strategies in Cosmetic Tattoo (Permanent make up) and Tattoo Removal
|
|
|
Συγγραφέας – Author
|
Foteini Biskanaki1, Vasiliki Kefala2 2Aesthetician Cosmetologist, Pharmacist Professor,, Department of Aesthetics and Cosmetology, School of Health and Caring Professions, |
|
|
Παραπομπή – Citation
|
Biskanaki F., Kefala V.: New Strategies in Cosmetic Tattoo (Permanent make up) and Tattoo Removal, Rev. Clin. Pharmacol. Pharmacokinet. 32: 17-21 (2018)
|
|
|
Ημερομηνία Δημοσιευσης – Publication Date
|
12-02-2018
|
|
|
Γλώσσα Πλήρους Κειμένου – Full Text Language
|
Αγγλικά – English
|
|
|
Λέξεις κλειδιά – Keywords
|
Permanent make up, Tattoo removal, Quality-switch lasers, Picosecond lasers
|
|
|
Λοιποί Όροι – Other Terms
|
άρθρο επισκόπησης |
|
|
Περίληψη – Summary
|
Tattoos have been chosen by people from all cultures and society for centuries. From the ancient Egyptian, Greek, and Roman cultures to the modern society, tattoo has been used to enhance beauty, demonstrate uniqueness, and signify belonging and sometimes to identify, shame, or punish. Techniques for tattoo removal have evolved significantly over the years. As more tattoos are being acquired, increasing numbers of people are also seeking their removal.(1) Techniques for tattoo have evolved significantly over the years and the most known are lasers Quality-switched (QS) ruby, alexandrite and Nd:YAG lasers. Newer strategies using combination laser treatments, multi – pass treatments and picosecond lasers offer promising results. (2) Some of the most important considerations when choosing the appropriate laser are tattoo color and skin type of the patient. There are standard protocols which can be developed the effective and safe treatment of tattoos.
|
|
|
Αναφορές – References
|
1. Unwanted tattoos. ASDS website. Available from:https://www.asds.net/Tattoo Removal Information.aspx. (2004) 2. Kefala Vasiliki. Biological cycle and skin, Review Clinical Pharmacology and Pharmacokinetics International Edition 33 (2), pp. 161-166 (2015) 3. Kluger N, Aldasouqi S. A new purpose for tattoos: Medical alert tattoos. Press e Med. 42:134–7 (2013) 4. Karatsi P., Kefala V., In vivo topical administration of propolis. Transdermal absorption study of the content of propolis in medicine and cosmetology products. A review. Epith. Klinikes Farmakologias kai Farmakokinetikes 33(3): 257-2642015 (2015) 5. Kirby W, Desai A, Desai T, Kartono F, Geeta P. The Kirby-Desai scale: A proposed scale to assess tattoo removal treatments. J Clin Aesth et Dermatol. 2:32–7. (2009) 6. Klein A, Rittmann I, Hiller KA, Landthaler M, Bäumler W. An internet-based survey on characteristics of laser tattoo removal and associated side effects. Lasers Med Sci.29:729–38 (2004) 7. Theodoropoulou, K., Kefala, V.Vitamins A and C: Their value as components of biologically active cosmeceuticals .Epitheorese Klinikes Farmakologias kai Farmakokinetikes 30 (1), pp.9-14 (2012 ) 8. Kefala, V. Skin changes and diseases in pregnancy .Review of Clinical Pharmacology and Pharmacokinetics, International Edition 19 (1) , pp. 23-26 (2005) 9. Leuenberger ML, Mulas MW, Hata TR, Goldman MP, Fitzpatrick RE, Grevelink JM. Comparison of the Qswitched alexandrite, Nd: YAG, and ruby laser in treating blue-black tattoos. Dermatol Surg. 25:10–4 (1999) 10. Kefala, V., Anthouli, F., Protopapa, E. The Use of Bleaching Agents in the Management of Melasma. Review of Clinical Pharmacology and Pharmacokinetics, International Edition .17 (3) , pp. 159-163 ( 2003) 11. Karsai S, Pfirrmann G, Hammes S, Raulin C. Treatment of resistant tattoos using a new generation Q-switched Nd: YAG laser: Influence of beam profile and spot size on clearance success. Lasers Surg Med. 40:139–45. (2008) 12. Kefala, V., Plessas, S.T. Topical and systemic therapeutic management of acne Review of Clinical Pharmacology and Pharmacokinetics, Int. Edition 14 (3) , pp. 101-110 (2000) 13. Kefala V. Acne: Clinical Forms &Treatments. Epitheorese Klinikes Farmakologias kai Farmakokinetikes .10(19): 63-76 (2001) 14. Kefala, V.Topicalanaesthetics in esthetic cosmetology and dermatology. Review of Clinical Pharmacology and Pharmacokinetics, International Edition 23 (3) , pp. 143- 145 ( 2009) 15. Kefala, V., Kostara, I., Karageorgiou, H., Varonos, D.D. In vitro model for the evaluation of preservatives phototoxic activity. Review of Clinical Pharmacology and Pharmacokinetics, International Edition .14 (2) , pp. 93- 96 (2000 ) 16. Kefala, V., Kostara, I., Karageorgiou, H., Varonos, D.D. In vitro model for evaluation of medicines phototoxic activity. Review of Clinical Pharmacology and Pharmacokinetics, International Edition .14 (1) , pp. 43-47 (2000 ) 17. Kefala, V., Kostara, I., Karageorgiou, H., Varonos, D.D. In vitro model for the evaluation of sunscreen agents phototoxic activity. Review of Clinical Pharmacology and Pharmacokinetics, International Edition 12 (1-2), pp. 59-62 (1998) 18. Kefala, V., Kostara, I., Karageorgiou, H., Varonos, D.D. In vitro model for the evaluation of essential oils phototoxic activity. Review of Clinical Pharmacology and Pharmacokinetics, International Edition .12 (1-2) , pp. 53-57 (1998) 19. Lapidoth M, Aharonowitz G. Tattoo removal among Ethiopian Jews in Israel: Tradition faces technology. J Am Acad Dermatol. 51:906–9. (2005) 20. Bukhari IA. Removal of amateur blue-black tattoos in Arabic women of skin type (III-IV) with Q-switched alexandrite laser. J Cosmet Dermatol. 4:107–10 (2005) 21. Guedes R, Leite L. Removal of orange eyebrow tattoo in a single session with the Q-switched Nd: YAG 532- nm laser. Lasers Med Sci. 25:465–6 (2010) 22. Fitzpatrick RE, Lupton JR. Successful treatment of treatment-resistant laser-induced pigment darkening of a cosmetic tattoo. Lasers Surg Med.27:358–61(2000) 23. Kirby W, Kaur RR, Desai A. Paradoxical darkening and removal of pink tattoo ink. J Cosmet Dermatol. 9:149–51 (2010) 24. Mafong EA, Kauvar AN, Geronemus RG. Surgical pearl: Removal of cosmetic lip-liner tattoo with the pulsed carbon dioxide laser. J Am Acad Dermatol. 48:271–2 (2003) 25. Wang CC, Huang CL, Yang AH, Chen CK, Lee SC, Leu FJ. Comparison of two Q-switched lasers and a shortpulse erbium-doped yttrium aluminum garnet laser for treatment of cosmetic tattoos containing titanium and iron in an animal model. Dermatol Surg. 36:1656–63. (2010) 26. Weiss ET, Geronemus RG. Combining fractional resurfacing and Q-switched ruby laser for tattoo removal. Dermatol Surg. 37:97–9 (2011) 27. Seitz AT, Grunewald S, Wagner JA, Simon JC, Paasch U. Fractional CO2 laser are as effective as Q-switchedruby-laser for the initial treatment of a traumatic tattoo. J Cosmet Laser Ther. 16:303–5.(2014) 28. Ibrahimi OA, Syed Z, Sakamoto FH, Avram MM, Anderson RR. Treatment of tattoo allergy with ablative fractional resurfacing: A novel paradigm for tattoo removal. J Am Acad Dermatol. 64:1111–4 (2011) 29. Wang CC, Huang CL, Lee SC, Sue YM, Leu FJ. Treatment of cosmetic tattoos with non-ablative fractional laser in an animal model: A novel method with histopathologic evidence. Lasers Surg Med. 45:116–22. (2013) 30. Wang CC, Huang CL, Sue YM, Lee SC, Leu FJ. Treatment of cosmetic tattoos using carbon dioxide ablative fractional resurfacing in an animal model: A novel method confirmed histopathologically. Dermatol Surg. 39:571–7(2013) 31. Kossida T, Rigopoulos D, Katsambas A, Anderson RR. Optimal tattoo removal in a single laser session based on the method of repeated exposures. J Am Acad Dermatol. 66:271–7 (2012) 32. Reddy KK, Brauer JA, Anolik R, Bernstein L, Brightman L, Hale E, et al. Topical perfluorodecalin resolves immediate whitening reactions and allows rapid effective multiple pass treatment of tattoos. Lasers Surg Med. 45:76–80 9 (2013) 33. Izikson L, Farinelli W, Sakamoto F, Tannous Z, Anderson RR. Safety and effectiveness of black tattoo clearance in a pig model after a single treatment with a novel 758 nm 500 picosecond laser: A pilot study. Lasers Surg Med. 42:640–6 (2010) 34. Saedi N, Metelitsa A, Petrell K, Arndt KA, Dover JS. Treatment of tattoos with a picosecond alexandrite laser: A prospective trial. Arch Dermatol. 148:1360–3. (2012) 35. Brauer JA, Reddy KK, Anolik R, Weiss ET, Karen JK, Hale EK, et al. Successful and rapid treatment of blue and green tattoo pigment with a novel picosecond laser. Arch Dermatol. 148:820–3 (2012) 36. Tanghetti EA, Tanghetti M. Dose optimization with a picosecond 755 nm alexandrite laser for tattoo removal. 34th American Society for Laser Medicine and Surgery (ASLMS) annual conference. Phoenix Arizona (2014) 37. Kilmer S, Custis T. Single vs repeat exposure tattoo removal during single sessions with picosecond pulse duration laser technology. 34th American Society for Laser Medicine and Surgery (ASLMS) annual conference. Phoenix Arizona (2014) 38. Klitzman B. Development of permanent but removable tattoos. First international conference on tattoo safety. BfR-Symposium Berlin; p. 23 (2013) |
|
|
Σχετικές Εργασίες – Relative Papers
|
Online ISSN 1011-6575
Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:
• Chemical Abstracts
• Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor
Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor
Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση-Οδηγίες προς τους Συγγραφείς What is Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition-Instrunctions to Authors
Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση Articles Published in Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition